Back to Home
Free CE/CMEVideo

Burst CME™: Burden of Sickle Cell Disease

Release Date

December 23, 2025

Expiration Date

December 24, 2026

Credits

0.25 CME

Specialties

Hematology, Blood Disorders+5 more

Release Date: December 23, 2025

Expiration Date: December 23, 2026

Activity Overview

Sickle cell disease (SCD) remains a complex, high-burden condition that significantly impacts patients across every stage of life. This educational program brings together leading clinical experts to provide a comprehensive examination of the physical, psychosocial, and healthcare-system challenges faced by individuals living with SCD. Drawing on decades of collective experience, faculty will review current epidemiology, the persistently high rates of acute and chronic complications, and the substantial morbidity associated with pain, organ damage, and reduced quality of life. Faculty will also interpret data through the lens of real-world clinical practice so that participants clinicians gain a deeper understanding of the lived experience of patients, the clinical complexities that challenge optimal care, and opportunities to improve outcomes across the continuum of SCD management.

Target Audience

This educational activity is primarily directed toward hematologists, NPs, and PAs. Other clinicians involved in the care of SCD will also be invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Outline the burden of disease for patients with SCD
Burst CME™: Burden of Sickle Cell Disease

GET STARTED WITH THIS PROGRAM:

Register now to gain access to this program.

Create AccountAlready Registered? Login Here

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Vertex Pharmaceuticals Incorporated.

Related Content

View All

Course

Burst CME™: Burden of Sickle Cell Disease

Create Account